提示：
1、投稿方式：在线投稿。
2、期刊网址：http://jem.rupress.org/
3、投稿网址：https://jem.msubmit.net/
4、官网邮箱：jem@rockefeller.edu
更多编辑邮箱请查看期刊该信息。
5、官网电话：212-327-8575
6、期刊刊期：月刊，一年出版12期。
2021年8月17日星期二
投稿须知【官网信息】
Instructions for Authors
Journal of Experimental Medicine is a monthly, peer-reviewed journal that publishes both original research as well as reviews and commentary. Manuscripts should be submitted via our online manuscript submission system. Prior to submission, please familiarize yourself with our Editorial Policies and detailed instructions on how to prepare your manuscript for Submitting to JEM.
About JEM
Aims and scope
Journal of Experimental Medicine (JEM) is a broad journal that publishes papers providing novel conceptual insight into immunology, cancer biology, vascular biology, microbial pathogenesis, neuroscience, and stem cell biology. We are interested in original findings on all aspects of disease pathogenesis, and we are happy to consider papers reporting novel therapeutic approaches. We strongly encourage submissions of human studies.
Criteria
To warrant publication in JEM, a manuscript must provide novel research findings of broad interest and clear in vivo relevance. Biomedical studies immediately relevant to disease will receive high priority.
Manuscript types
Articles present comprehensive studies providing novel and significant insight into an area of interest to our general readership. Articles are fully documented reports of original research, but should be as concise as possible without compromising the documentation of the data. Manuscripts containing purely descriptive observations or reports of new techniques in the absence of new biological insights will not be considered. Articles should be no more than 40,000 characters (not including spaces, methods, or references), with up to10 figures and/or tables. Articles may have up to five supplemental figures and references are unlimited.
Brief Definitive Reports (BDRs) are shorter than Articles and present observations of immediate impact. Findings suitable for BDRs include those that are definitive yet extremely surprising and hold the potential to initiate new avenues of research, those that answer long-standing open questions or settle controversies of broad interest, and those that provide a concise conceptual advance in a rapidly moving field. The length limit for BDRs is 20,000 characters (not including spaces, methods, or references), with up to five figures and/or tables. BDRs may have up to three supplemental figures and references are unlimited.
Technical Advances and Resources are primary research studies reporting a novel technique or dataset that advances pre-clinical or clinical research and is of immediate value to our broad readership. Manuscripts containing purely descriptive reports of new techniques in the absence of new biological insights will not be considered. Validation of the new technique and demonstration of its advantage over existing approaches should be provided. For datasets, authors must provide a compelling proof of principle that analysis of the dataset yields novel biological insights. The length limit for Technical Advances and Resources is 40,000 characters (not including spaces, methods, or references), with up to 10 figures and/or tables. Technical Advances and Resources may have up to five supplemental figures and references are unlimited.
……
更多详情：
https://rupress.org/jem/pages/ifora
